🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, claiming the corporations hid safety concerns that the drug created to pediatric neurological development.

This legal action comes thirty days after Former President Trump promoted an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in young ones.

The attorney general is filing suit against Johnson & Johnson, which once produced the drug, the exclusive pain medication recommended for expectant mothers, and Kenvue, which currently produces it.

In a statement, he said they "betrayed America by profiting off of discomfort and marketing drugs ignoring the potential hazards."

The company says there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These corporations lied for decades, intentionally threatening numerous people to boost earnings," Paxton, a Republican, declared.

The company said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the health of American women and children."

On its official site, the company also said it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a established connection between taking acetaminophen and autism."

Groups representing physicians and healthcare providers concur.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in acetaminophen - is among limited choices for expectant mothers to manage pain and elevated temperature, which can pose significant medical dangers if not addressed.

"In more than two decades of research on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the use of acetaminophen in any stage of gestation leads to neurological conditions in children," the group commented.

The lawsuit cites recent announcements from the former administration in arguing the drug is potentially dangerous.

Last month, Trump raised alarms from health experts when he advised expectant mothers to "struggle intensely" not to use acetaminophen when unwell.

The FDA then published an announcement that medical professionals should consider limiting the consumption of acetaminophen, while also stating that "a direct connection" between the drug and autism in young ones has not been proven.

Health Secretary RFK Jr, who oversees the FDA, had pledged in April to conduct "comprehensive study program" that would determine the origin of autism spectrum disorder in a limited time.

But specialists warned that discovering a unique factor of autism - considered by experts to be the outcome of a intricate combination of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and disability that impacts how people experience and relate to the environment, and is identified using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is running for the Senate - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the science" around paracetamol and autism spectrum disorder.

This legal action seeks to make the companies "remove any commercial messaging" that asserts Tylenol is reliable for women during pregnancy.

The Texas lawsuit mirrors the complaints of a group of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

A federal judge rejected the case, declaring studies from the family's specialists was lacking definitive proof.